Skip to content
AnalystLens

FortiveFTV

Legal name
Fortive Corporation
Industry
Industrial Instruments For Measurement, Display, and Control
Exchange
NYSE

Stock Price $FTV

Filing record · 2016–202610-K1010-Q328-K120

FTV filed 10 annual reports (10-K), 32 quarterly reports (10-Q) and 120 current reports (8-K) between 2016 and 2026.

  1. FY2016 annual report10-K · Feb ’17Feb ’17
  2. Deal closed8-K · Jun ’19Jun ’19
  3. Leadership change8-K · Jan ’22Jan ’22
  4. Leadership change8-K · Oct ’25Oct ’25
Source: 10-KFY2026
Source: 10-KFY2026
Source: 10-KFY2026
Source: 10-KFY2026

Revenue Trend

Year-over-year comparison from 10-K annual reports

  1. $3.27B
YoY changeLargest recent move−34.0%in FY18Latest −21.3%

Latest bar from 10-KFY2026Click a bar to open its SEC filing

View full history →

Fortive Financial Overview 2021–2025

Updated Nov 4, 2026

Fortive spent $1.61 billiona buying back 30.4 million shares in FY2025, roughly 9% of the $17.3 billion market cap it carried at that year's close. That is the thesis. After spinning off Ralliant on June 28, 2025, Fortive is a smaller company that turns pricing power and cash flow into per-share gains, and its growth has picked up since.

The scale shrank, but the margins improved. Sales fell from $5.25 billion in FY2021 to $4.16 billionb in FY2025, mostly because Precision Technologies left. Over the same span, operating margin widened from 15.5% to 17.3%. Pricing did the work: 2.2% price gains in FY2025 more than offset a 0.6% volume decline. Operating cash flow from continuing operations reached $1.04 billion, and net interest expense dropped to $120.5 million from $152.8 million.

Momentum has built since. In Q3 2026, sales rose to $1.11 billionc, core growth hit 7.2%, and operating profit jumped to $235.9 million from $159.6 million. Buybacks hit $1.0 billion in the first nine months of 2026, while long-term debt rose to $3.51 billion from $2.31 billion at the end of FY2025. The market was not cheap on this story. Fortive closed FY2025 at $55.21, or 31.9x trailing EPS of $1.73.

Recent Developments (Q2 and Q3 2026)

Fortive raised full-year 2026 adjusted EPS guidance twice. It moved to $2.95 to $3.05 after Q2 2026, then to $3.10 to $3.14d after Q3 2026, about 15% growth at the midpoint. Adjusted EBITDA margin rose to 30.6% in Q3 2026 from 29.5% in Q2 2026. Q3 GAAP EPS of $0.57 rose 62.9%, helped by a weak comparison that included $33 million of separation stock compensation. In May 2026, Fortive sold $1.1 billion of notes due 2031 and 2036 and repaid the 3.15% notes. Susan Main joined the board on September 9, 2026.

Bulls point to buybacks of about $2.3 billione since the new Fortive launched, plus $1.06 billion of trailing free cash flow. Bears point to Advanced Healthcare, where adjusted EBITDA margin fell to 25.8% from 28.1%, and to a valuation of 42.5x earnings as of the October 27, 2026 report date, not today.

What to watch: Advanced Healthcare margin recovery; debt levels as buybacks continue

Recent SEC Filings

  1. 8-KFortive 8-K Report, Financial Results (Oct 28, 2026)Fortive Corporation reported third-quarter 2026 results for the quarter ended October 2, 2026, in a press release furnished as Exhibit 99.1 under Item 2.02. Revenue was $1.11 billion, up 7.8% year-over-year on a reported basis and 7.2% on a core basis. GAAP net earnings were $173 million, up 47.4%, and GAAP diluted EPS was $0.57, up 62.9%. Adjusted diluted EPS was $0.77, up 13.2%, and adjusted EBITDA was $339 million, up 9.5%, at a 30.6% margin. Operating cash flow was $313 million and free cash flow was $284 million, with trailing twelve-month free cash flow of $1,062 million. The company raised its FY 2026 adjusted diluted EPS guidance to $3.10 to $3.14, which the filing describes as up approximately 15% year-over-year at the midpoint. Management said it deployed approximately $300 million toward share repurchases in the quarter, about 5 million shares or 2% of diluted shares outstanding. Since the launch of new Fortive, total repurchases reached approximately $2.3 billion, or about 43 million shares, representing approximately 13% of shares outstanding. By segment, Intelligent Operating Solutions revenue was $767 million, up 9.8% reported and 9.1% core, with a 35.8% adjusted EBITDA margin. Advanced Healthcare Solutions revenue was $340 million, up 3.7% reported and 3.1% core, but its GAAP operating margin fell to 11.2% from 12.9%, and its adjusted EBITDA margin declined to 25.8% from 28.1%. Q3 2025 GAAP results included discontinued operations tied to the June 2025 separation of Ralliant Corporation, and GAAP results this quarter benefited from $18.0 million in pretax IEEPA tariff refunds, which the company excluded from its adjusted measures.
  2. 8-KFortive 8-K Report, Executive Changes (Sep 10, 2026)Fortive Corporation filed a Form 8-K dated September 10, 2026 under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). The filing reports that, effective September 9, 2026, the Board of Directors increased its size from eight to nine members and appointed Susan L. Main as a director. Her term runs from September 9, 2026 until the 2027 Annual Meeting of Shareholders, or until her successor is duly elected and qualified. The Board also concurrently appointed Ms. Main to the Audit Committee. The Board determined that Ms. Main is independent under the New York Stock Exchange listing standards and is an audit committee financial expert as defined in Item 407(d) of Regulation S-K. The filing states that there is no arrangement or understanding between Ms. Main and any other person under which she was selected as a director, and that there are no transactions requiring disclosure under Item 404(a) of Regulation S-K. As a non-employee director, Ms. Main will receive the same compensation as the Company's other non-employee directors, as described in Exhibit 10.1 to the Company's Form 10-Q for the fiscal quarter ended July 3, 2026. She has also entered into the Company's standard indemnification agreement, incorporated by reference from Exhibit 10.10 to Amendment No. 2 to the Company's Form 10 registration statement filed April 7, 2016.
  3. 8-KFortive 8-K Report, Financial Results (Jul 29, 2026)Fortive Corporation reported second-quarter 2026 results for the quarter ended July 3, 2026. Revenue was $1,096.8 million, up 7.9% year-over-year on a reported basis and 6.7% on a core basis. GAAP net earnings from continuing operations were $157.3 million, up 40.9%, and GAAP diluted EPS was $0.51, up 54.5%. Adjusted EBITDA was $323.1 million, up 12.0%, with an adjusted EBITDA margin of 29.5%. Adjusted diluted EPS was $0.74, up 28.5%. By segment, Intelligent Operating Solutions revenue was $758.2 million, up 8.8% (7.4% core), with an adjusted EBITDA margin of 34.9%. Advanced Healthcare Solutions revenue was $338.6 million, up 6.0% (5.3% core), and its adjusted EBITDA margin was 26.1%, down 80 basis points. Operating cash flow from continuing operations was $298.7 million and free cash flow was $270.6 million, with trailing twelve-month free cash flow of $1,044.3 million. Management raised its full-year 2026 adjusted diluted EPS guidance to $2.95 to $3.05. The company repurchased approximately $200 million of shares in the quarter and about $2 billion over the last four quarters. The balance sheet shows long-term debt rising to $3,509.3 million from $2,306.5 million at December 31, 2025, while the current portion of long-term debt fell to zero from $899.5 million.
  4. 8-KFortive 8-K Report, Shareholder Vote Results (Jun 11, 2026)Fortive Corporation filed this Current Report on Form 8-K dated June 11, 2026, under Item 5.07 (Submission of Matters to a Vote of Security Holders). The filing reports the results of the company's annual meeting of shareholders held on June 9, 2026, at which shareholders voted on three proposals. All eight director nominees named in the proxy statement were elected to one-year terms expiring at the 2027 annual meeting. Each nominee received substantially more votes for than against. Kate D. Mitchell received the most against votes (9,895,494), and Olumide Soroye received the fewest (504,101). Shareholders also approved, on an advisory basis, the compensation of the named executive officers, with 265,946,471 votes for and 15,686,260 against. Ernst & Young LLP was ratified as the independent registered public accounting firm for the year ending December 31, 2026, with 274,297,484 votes for and 16,324,999 against. For investors, the filing shows that the board slate, the executive pay proposal, and the auditor ratification all passed. The filing reports 8,872,467 broker non-votes on the director and say-on-pay proposals, but it does not describe any other corporate action, financial result, or strategic development.
  5. 8-KFortive 8-K Report, Material Agreement (May 14, 2026)Fortive Corporation, a Delaware corporation, completed an underwritten offering on May 14, 2026 of $600 million aggregate principal amount of its 4.750% Notes due 2031 and $500 million aggregate principal amount of its 5.250% Notes due 2036. The notes are general unsecured obligations that rank equally in right of payment with the company's existing and future unsecured, unsubordinated indebtedness and are not guaranteed. Interest is payable semi-annually on May 15 and November 15, beginning November 15, 2026. The company intends to use the net proceeds to refinance certain indebtedness, including repaying at maturity its 3.150% senior notes due June 15, 2026 (plus accrued and unpaid interest), to pay related fees and expenses, and for general corporate purposes. The 2031 notes are redeemable at a make-whole price before April 15, 2031 and at par thereafter; the 2036 notes are redeemable at a make-whole price before February 15, 2036 and at par thereafter. The Indenture, with Truist Bank as trustee, limits the company's ability, subject to exceptions, to incur secured indebtedness, enter into sale and leaseback transactions, and consummate a merger, consolidation or sale of substantially all assets. If a change of control triggering event (a change of control plus a rating event) occurs, the company must offer to repurchase the notes at 101% of principal plus accrued and unpaid interest. The offering was made under an effective Form S-3 shelf registration statement and a prospectus supplement dated May 12, 2026, with the underwriting agreement dated May 12, 2026 among Morgan Stanley & Co LLC, Barclays Capital Inc., J.P. Morgan Securities LLC and Scotia Capital (USA) Inc. as managers.
View all 8-K filings →